Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Li Yishan converted 1,838,896 Blossomhill Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 10, 2026
On Aug 10, 2026, Li Yishan (Director, Executive Chairman, 10% owner) converted 1,838,896 Blossomhill Therapeutics, Inc. shares, leaving 124,779 shares. Filed Aug 10, 2026 (Form 4).
- Converted
- 1,838,896 shares
- Holding after
- 124,779 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Executive Chairman, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Conversion | 1,600,682 | 1,600,682 | Indirect | |
| Aug 10, 2026 | Common Stock | Conversion | 113,435 | 1,714,117 | Indirect | |
| Aug 10, 2026 | Common Stock | Conversion | 124,779 | 124,779 | Indirect |
Source
Related
- Blossomhill Therapeutics, Inc.
- Li Yishan
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026